Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Balking at marketing slapdown, Galderma declares itself pharma non grata
Fierce Pharma Marketing
Tuesday, October 7, 2014 - 11:55am
tags:
Galderma, PCMPA
Report: Financial conflicts sway studies of flu fighters Tamiflu and Relenza
Fierce Pharma
Tuesday, October 7, 2014 - 11:50am
tags:
influenza, Tamiflu, RELENZA, GSK, Roche
Positive PhIII PONV study brings little Acacia to a crossroads
Fierce Biotech
Tuesday, October 7, 2014 - 11:48am
tags:
Acacia Pharma, PONV
Zoetis Will Benefit from Industry Trends
Yahoo/Gurufocus
Tuesday, October 7, 2014 - 11:26am
tags:
Zoetis, animal health
Hyperion, Clal Biotech resolve dispute over diabetes drug
Yahoo/Reuters
Tuesday, October 7, 2014 - 11:25am
tags:
Hyperion, Clal Biotech, diabetes, DiaPep277
Novartis takes three licenses to ImmunoGen drug targets
Seeking Alpha
Tuesday, October 7, 2014 - 11:19am
tags:
Novartis, Immunogen
Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field
First Word Pharma
Tuesday, October 7, 2014 - 8:48am
tags:
Bristol-Myers Squibb, asunaprevir, hepatitis C
Top execs bicker over Sanofi's plan to unload $8B portfolio of old drugs
Fierce Pharma
Tuesday, October 7, 2014 - 8:34am
tags:
Sanofi
Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Fierce Pharma
Tuesday, October 7, 2014 - 8:09am
tags:
Sovaldi, UK, drug pricing, Gilead Sciences, hepatitis C
Medtronic Enters Market For Smartphone-enabled Glucose Monitoring Systems
Bidness Etc.
Tuesday, October 7, 2014 - 7:47am
tags:
Medtronic, diabetes, devices, blood glucose monitoring, Medtronic Guardian Mobile, smartphones
AbbVie's Humira Receives FDA Approval for JIA
Drug Discovery and Development
Tuesday, October 7, 2014 - 7:45am
tags:
AbbVie, Humira, FDA, juvenile idiopathic arthritis
FDA approves emergency use of Chimerix's Brincidofovir
Seeking Alpha
Tuesday, October 7, 2014 - 7:43am
tags:
FDA, Chimerix, Brincidofovir, ebola virus
Allergan Asks Judge to Block Ackman From Voting Stock at Meeting
Bloomberg
Tuesday, October 7, 2014 - 7:39am
tags:
Allergan, Valeant Pharmaceuticals, Bill Ackman, M&A
BrainStorm gets FDA fast-track status for ALS stem cell therapy
Yahoo/Reuters
Tuesday, October 7, 2014 - 7:38am
tags:
BrainStorm Cell Therapeutics, FDA, ALS, stem cells
Number of companies fighting Ebola grows, one wins fed OK
Marketwatch
Monday, October 6, 2014 - 9:28pm
tags:
ebola virus, Chimerix, Tekmira Pharmaceuticals, NewLink Genetics, NanoViricides, Crucell, GSK
Sanofi Notifies U.S. About Overseas Bribery Allegations
Bloomberg
Monday, October 6, 2014 - 9:22pm
tags:
Sanofi, bribery, Africa, Middle East
Is Teva knocking on Mylan's door? With inversion deal at risk, maybe
Fierce Pharma
Monday, October 6, 2014 - 6:45pm
tags:
Teva Pharmaceutical, Mylan Labs, tax inversions, M&A
Mylan Surges on Improved Q3 and Full-Year Earnings Outlook
Yahoo/Zacks.com
Monday, October 6, 2014 - 6:42pm
tags:
earnings, Mylan Labs
Will Biotech Beat This Earnings Season?
Barron's
Monday, October 6, 2014 - 6:05pm
tags:
earnings, Gilead Sciences, Celgene, Biogen Idec
Sanofi And Novo Nordisk‘s Basal-Insulin Battle Continues
Bidness Etc.
Monday, October 6, 2014 - 11:51am
tags:
Sanofi, Novo Nordisk, basal insulin, diabetes, Lantus, Levemir

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.